The effect of novel magnetic nanoparticles on vascular endothelial cell function in vitro and in vivo

Journal of Hazardous Materials

Volumn 235-236, Issue , 2012, Pages 316-325

  Su, Le ^a   Han, Lei ^a   Ge, Fei ^a   Zhang, Shang Li ^a   Zhang, Yun ^b   Zhao, Bao Xiang ^a   Zhao, Jing ^a   Miao, Jun Ying ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Caveolin 1; ENOS; Magnetic nanoparticles; NO; Vascular endothelial cells

Indexed keywords

AORTIC ROOT; CATIONIC DYES; CAVEOLIN-1; ENDOTHELIAL NITRIC-OXIDE SYNTHASE (ENOS); ENOS; HIGH CONCENTRATION; HUMAN HEALTH; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IN-VITRO; LOW CONCENTRATIONS; MAGNETIC NANOPARTICLES; VASCULAR ENDOTHELIAL CELLS;

BIOCOMPATIBILITY; CELL PROLIFERATION; ENDOTHELIAL CELLS; HEAVY METALS; METAL IONS; NITRIC OXIDE; NOBELIUM; TOXICITY;

NANOPARTICLES;

CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MAGNETIC NANOPARTICLE; NITRIC OXIDE;

ANTIBODY; AQUEOUS SOLUTION; CARDIOVASCULAR SYSTEM; CYTOLOGY; ECOTOXICOLOGY; ENZYME ACTIVITY; HEALTH RISK; INHIBITION; MAGNETIC FIELD; NANOTECHNOLOGY; NITRIC OXIDE; PARTICLE SIZE; POLLUTANT REMOVAL; PROTEIN; PUBLIC HEALTH;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; BIOCOMPATIBILITY; CELL FUNCTION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CAVEOLIN 1; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MAGNETIC PHENOMENA; MAGNETITE NANOPARTICLES; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON, TRANSMISSION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III;

MUS;

EID: 84865798219     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2012.08.003     Document Type: Article

References (34)

1. Assadi M., Afrasiabi K., Nabipour I., Seyedabadi M. Nanotechnology and nuclear medicine; research and preclinical applications. Hell. J. Nucl. Med. 2011, 14:149-159.
2. Hahn M.A., Singh A.K., Sharma P., Brown S.C., Moudgil B.M. Nanoparticles as contrast agents for in vivo bioimaging: current status and future perspectives. Anal. Bioanal. Chem. 2011, 399:3-27.
3. Oesterling E., Chopra N., Gavalas V., Arzuaga X., Lim E.J., Sultana R., Butterfield D.A., Bachas L., Hennig B. Alumina nanoparticles induce expression of endothelial cell adhesion molecules. Toxicol. Lett. 2008, 178:160-166.
4. Maynard A.D. Nanotechnology: A Research Strategy for Addressing Risk 2006, Woodrow Wilson International Center for Scholars, Washington, DC.
5. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 2010, 267:89-105.
6. Pope C.A., Burnett R.T., Thurston G.D., Thun M.J., Calle E.E., Krewski D., Godleski J.J. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 2004, 109:71-77.
7. Bai N., Khazaei M., van Eeden S.F., Laher I. The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction. Pharmacol. Ther. 2007, 113:16-29.
8. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med. 2004, 15:321-325.
9. Shimada A., Kawamura N., Okajima M., Kaewamatawong T., Inoue H., Morita T. Translocation pathway of the intratracheally instilled ultrafine particles from the lung into the blood circulation in the mouse. Toxicol. Pathol. 2006, 34:949-957.
10. Zhu M.T., Feng W.Y., Wang Y., Wang B., Wang M., Ouyang H., Zhao Y.L., Chai Z.F. Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol. Sci. 2009, 107:342-351.
11. Donnini D., Perrella G., Stel G., Ambesi-Impiombato F.S., Curcio F. A new model of human aortic endothelial cells in vitro. Biochimie 2000, 82:1107-1114.
12. Gibbons G.H. Endothelial function as a determinant of vascular function and structure: a new therapeutic target. Am. J. Cardiol. 1997, 79:3-8.
13. Gojova A., Guo B., Kota R.S., Rutledge J.C., Kennedy I.M., Barakat A.I. Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition. Environ. Health Perspect. 2007, 115:403-409.
14. Nurkiewicz T.R., Porter D.W., Barger M., Castranova V., Boegehold M.A. Particulate matter exposure impairs systemic microvascular endothelium-dependent dilation. Environ. Health Perspect. 2004, 112:1299-1306.
15. Navarro E., Piccapietra F., Wagner B., Marconi F., Kaegi R., Odzak N., Sigg L., Behra R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 2008, 42:8959-8964.
16. Ge F., Li M.M., Ye H., Zhao B.X. Effective removal of heavy metal ions Cd(2+), Zn(2+), Pb(2+), Cu(2+) from aqueous solution by polymer-modified magnetic nanoparticles. J. Hazard. Mater. 2012, 211-212:366-372.
17. Ge F., Ye H., Li M.M., Zhao B.X. Efficient removal of cationic dyes from aqueous solution by polymer-modified magnetic nanoparticles. Chem. Eng. J. 2012, 198(199):11-17.
18. Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973, 52:2745-2756.
19. Su L., Zhao J., Zhao B.X., Miao J.Y., Yin D.L., Zhang S.L. Safrole oxide induced human umbilical vein vascular endothelial cell differentiation into neuron-like cells by depressing the reactive oxygen species level at the low concentration. Biochim. Biophys. Acta 2006, 1763:247-253.
20. Su L., Zhao J., Zhao B.X., Zhang S.L., Miao J.Y. Safrole oxide induces human umbilical vein endothelial cell transdifferentiation to 5-hydroxytryptaminergic neuron-like cells through tropomyosin receptor kinase A/cyclooxygenase 2/nuclear factor-kappa B/interleukin 8 signaling. Int. J. Biochem. Cell Biol. 2011, 43:1512-1522.
21. Chen W.L., Qian Y., Meng W.F., Pang J.Y., Lin Y.C., Guan Y.Y., Chen S.P., Liu J., Pei Z., Wang G.L. A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro. Biochem. Pharmacol. 2009, 78:941-950.
22. Voyta J.C., Via D.P., Butterfield C.E., Zetter B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 1984, 99:2034-2040.
23. Rafikov R., Fonseca F.V., Kumar S., Pardo D., Darragh C., Elms S., Fulton D., Black S.M. eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. J. Endocrinol. 2011, 210:271-284.
24. Mehta D., Malik A.B. Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 2006, 86:279-367.
25. Apopa P.L., Qian Y., Shao R., Guo N.L., Schwegler-Berry D., Pacurari M., Porter D., Shi X., Vallyathan V., Castranova V., Flynn D.C. Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part. Fibre Toxicol. 2009, 6:1.
26. Zhu M.T., Wang B., Wang Y., Yuan L., Wang H.J., Wang M., Ouyang H., Chai Z.F., Feng W.Y., Zhao Y.L. Endothelial dysfunction and inflammation induced by iron oxide nanoparticle exposure: risk factors for early atherosclerosis. Toxicol. Lett. 2011, 203:162-171.
27. Bobryshev Y.V. Monocyte recruitment and foam cell formation in atherosclerosis. Micron 2006, 37:208-222.
28. Chao C.C., Park S.H., Aust A.E. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch. Biochem. Biophys. 1996, 326:152-157.
29. Ducsay C.A., Myers D.A. eNOS activation and NO function: differential control of steroidogenesis by nitric oxide and its adaptation with hypoxia. J. Endocrinol. 2011, 210:259-269.
30. Shaul P.W., Smart E.J., Robinson L.J., German Z., Yuhanna I.S., Ying Y., Anderson R.G., Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996, 271:6518-6522.
31. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J. Biol. Chem. 1997, 272:18522-18525.
32. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell 1992, 68:673-682.
33. 2+-calmodulin and caveolin. J. Biol. Chem. 1997, 272:15583-15586.
34. Schubert W., Frank P.G., Woodman S.E., Hyogo H., Cohen D.E., Chow C.W., Lisanti M.P. Microvascular hyperpermeability in caveolin-1(-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, l-NAME, restores normal microvascular permeability in Cav-1 null mice. J. Biol. Chem. 2002, 277:40091-40098.